Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Daily News

Lotus Valve’s Return to Market in Europe Sees Further Delays

Shelley Wood

November 29, 2017

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

Presentation PCR London Valves 2017

Influence of Gender on Clinical Outcomes Following TAVI with a Retrievable and Fully Repositionable Aortic Valve

Presenter: Anna-Sonio Petronio

September 25, 2017

News Daily News

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

L.A. McKeown

July 26, 2017

Presentation TVT 2017

Who Shouldnt Undergo TAVR? Can We Identify Non-responders?

Presenter: David J. Cohen, Mark J. Russo, Suzanne V. Arnold

June 16, 2017

Presentation TVT 2017

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Presenter: Mark Reisman, Gregg W. Stone, Robert O. Bonow

June 15, 2017

News Industry News

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

May 15, 2017

News Daily News

Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care

Yael L. Maxwell

April 14, 2017

News Features

Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table?

Caitlin E. Cox

March 31, 2017

News Conference News CRT 2017

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Michael O'Riordan

February 22, 2017

News Daily News

Prosthesis-Patient Mismatch After Aortic Valve Replacement Declining but Tied to Poorer Survival

Todd Neale

January 25, 2017

Advertisement

Lotus Valve’s Return to Market in Europe Sees Further Delays

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Influence of Gender on Clinical Outcomes Following TAVI with a Retrievable and Fully Repositionable Aortic Valve

Newly Proposed Classification of AS Focuses on Baseline Cardiac Damage as Outcome Predictor

Who Shouldnt Undergo TAVR? Can We Identify Non-responders?

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

The Boston Scientific LOTUS™ Valve System Demonstrated Superior Efficacy to CoreValve® in Global REPRISE III Trial at One Year

Comrades in TAVR? Cardiac Surgeons Say They’re Involved in All Stages of TAVR Care

Living or Leaving: Does Palliative Care Deserve a Place at the TAVR Table?

Lotus TAVR Device With Depth Guard Reduces Risk of Pacemaker Implantation

Prosthesis-Patient Mismatch After Aortic Valve Replacement Declining but Tied to Poorer Survival

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content